GlassScriptPhysician profile
Jin Woo Chung
NPI 1992131312
$5,382.47
in general payments reported to CMS, 2019-2025
8 companies · $4,569 in 2025
The $4,569 reported for 2025 was more than what 81% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.64 · 2023: $612 · 2024: $181 · 2025: $4,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,031 · Food and Beverage: $1,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,031.44 |
| Food and Beverage | $1,331.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,487.17 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit, Navitor, 2nd Gen Centrimag Primary Console |
| Transmedics, INC. | $1,608.36 | 2025 | Organ Care System |
| Abiomed | $523.05 | 2023-2025 | Impella |
| Xvivo Perfusion INC. | $497.66 | 2023 | |
| Atricure, INC. | $121.93 | 2024 | |
| Philips North America LLC | $96.09 | 2025 | Lm Undivided |
| Paragonix Technologies, INC. | $28.57 | 2025 | |
| Edwards Lifesciences Corporation | $19.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Woo Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.